Aducanumab (Aduhelm) For Alzheimer’s Disease
Aducanumab (Aduhelm) at the University of Florida On June 7, 2021, the FDA approved the medication Aducanumab (Aduhelm) for use in Alzheimer’s disease. Amyloid beta may be an important protein in the progression of Alzheimer’s disease. Aduhelm is an antibody (i.e., a protein that helps your immune system to remove…
